These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 24002594)
1. Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). Pesatori AC; Carugno M; Consonni D; Hung RJ; Papadoupolos A; Landi MT; Brenner H; Müller H; Harris CC; Duell EJ; Andrew AS; McLaughlin JR; Schwartz AG; Wenzlaff AS; Stucker I Br J Cancer; 2013 Oct; 109(7):1954-64. PubMed ID: 24002594 [TBL] [Abstract][Full Text] [Related]
2. Reproductive and hormonal factors and the risk of lung cancer: the EAGLE study. Pesatori AC; Carugno M; Consonni D; Caporaso NE; Wacholder S; Tucker M; Landi MT Int J Cancer; 2013 Jun; 132(11):2630-9. PubMed ID: 23129166 [TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis. Lagergren K; Lagergren J; Brusselaers N Int J Cancer; 2014 Nov; 135(9):2183-90. PubMed ID: 24676860 [TBL] [Abstract][Full Text] [Related]
4. Cigarette smoking and lung cancer risk according to histologic type in Japanese men and women. Seki T; Nishino Y; Tanji F; Maemondo M; Takahashi S; Sato I; Kawai M; Minami Y Cancer Sci; 2013 Nov; 104(11):1515-22. PubMed ID: 23992614 [TBL] [Abstract][Full Text] [Related]
5. A pooled analysis of case-control studies of thyroid cancer. III. Oral contraceptives, menopausal replacement therapy and other female hormones. La Vecchia C; Ron E; Franceschi S; Dal Maso L; Mark SD; Chatenoud L; Braga C; Preston-Martin S; McTiernan A; Kolonel L; Mabuchi K; Jin F; Wingren G; Galanti MR; Hallquist A; Lund E; Levi F; Linos D; Negri E Cancer Causes Control; 1999 Apr; 10(2):157-66. PubMed ID: 10231164 [TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Pesch B; Kendzia B; Gustavsson P; Jöckel KH; Johnen G; Pohlabeln H; Olsson A; Ahrens W; Gross IM; Brüske I; Wichmann HE; Merletti F; Richiardi L; Simonato L; Fortes C; Siemiatycki J; Parent ME; Consonni D; Landi MT; Caporaso N; Zaridze D; Cassidy A; Szeszenia-Dabrowska N; Rudnai P; Lissowska J; Stücker I; Fabianova E; Dumitru RS; Bencko V; Foretova L; Janout V; Rudin CM; Brennan P; Boffetta P; Straif K; Brüning T Int J Cancer; 2012 Sep; 131(5):1210-9. PubMed ID: 22052329 [TBL] [Abstract][Full Text] [Related]
7. Exposure to secondhand tobacco smoke and lung cancer by histological type: a pooled analysis of the International Lung Cancer Consortium (ILCCO). Kim CH; Lee YC; Hung RJ; McNallan SR; Cote ML; Lim WY; Chang SC; Kim JH; Ugolini D; Chen Y; Liloglou T; Andrew AS; Onega T; Duell EJ; Field JK; Lazarus P; Le Marchand L; Neri M; Vineis P; Kiyohara C; Hong YC; Morgenstern H; Matsuo K; Tajima K; Christiani DC; McLaughlin JR; Bencko V; Holcatova I; Boffetta P; Brennan P; Fabianova E; Foretova L; Janout V; Lissowska J; Mates D; Rudnai P; Szeszenia-Dabrowska N; Mukeria A; Zaridze D; Seow A; Schwartz AG; Yang P; Zhang ZF Int J Cancer; 2014 Oct; 135(8):1918-30. PubMed ID: 24615328 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Koushik A; Parent ME; Siemiatycki J Int J Cancer; 2009 Nov; 125(10):2428-33. PubMed ID: 19585503 [TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and lung cancer risk: a case-control analysis. Schabath MB; Wu X; Vassilopoulou-Sellin R; Vaporciyan AA; Spitz MR Clin Cancer Res; 2004 Jan; 10(1 Pt 1):113-23. PubMed ID: 14734459 [TBL] [Abstract][Full Text] [Related]
10. Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer? Birch-Johansen F; Jensen A; Olesen AB; Christensen J; Tjønneland A; Kjær SK Cancer Causes Control; 2012 Feb; 23(2):379-88. PubMed ID: 22215431 [TBL] [Abstract][Full Text] [Related]
11. Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer Consortium. Rosenberger A; Bickeböller H; McCormack V; Brenner DR; Duell EJ; Tjønneland A; Friis S; Muscat JE; Yang P; Wichmann HE; Heinrich J; Szeszenia-Dabrowska N; Lissowska J; Zaridze D; Rudnai P; Fabianova E; Janout V; Bencko V; Brennan P; Mates D; Schwartz AG; Cote ML; Zhang ZF; Morgenstern H; Oh SS; Field JK; Raji O; McLaughlin JR; Wiencke J; LeMarchand L; Neri M; Bonassi S; Andrew AS; Lan Q; Hu W; Orlow I; Park BJ; Boffetta P; Hung RJ Carcinogenesis; 2012 Mar; 33(3):587-97. PubMed ID: 22198214 [TBL] [Abstract][Full Text] [Related]
12. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy? Khoo SK; Chick P Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053 [TBL] [Abstract][Full Text] [Related]
13. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies. Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589 [TBL] [Abstract][Full Text] [Related]
14. Association of oral contraceptives use and lung cancer risk among women: an updated meta-analysis based on cohort and case-control studies. Wu W; Yin ZH; Guan P; Ren YW; Zhou BS Asian Pac J Cancer Prev; 2014; 15(3):1205-10. PubMed ID: 24606442 [TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study. Lund E; Bakken K; Dumeaux V; Andersen V; Kumle M Int J Cancer; 2007 Aug; 121(3):645-8. PubMed ID: 17372914 [TBL] [Abstract][Full Text] [Related]
16. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. Zhang LR; Morgenstern H; Greenland S; Chang SC; Lazarus P; Teare MD; Woll PJ; Orlow I; Cox B; ; Brhane Y; Liu G; Hung RJ Int J Cancer; 2015 Feb; 136(4):894-903. PubMed ID: 24947688 [TBL] [Abstract][Full Text] [Related]
17. Alcohol consumption and lung cancer risk: A pooled analysis from the International Lung Cancer Consortium and the SYNERGY study. Brenner DR; Fehringer G; Zhang ZF; Lee YA; Meyers T; Matsuo K; Ito H; Vineis P; Stucker I; Boffetta P; Brennan P; Christiani DC; Diao N; Hong YC; Landi MT; Morgenstern H; Schwartz AG; Rennert G; Saliba W; McLaughlin JR; Harris CC; Orlow I; Barros Dios JM; Ruano Raviña A; Siemiatycki J; Koushik A; Cote M; Lazarus P; Fernandez-Tardon G; Tardon A; Le Marchand L; Brenner H; Saum KU; Duell EJ; Andrew AS; Consonni D; Olsson A; Hung RJ; Straif K Cancer Epidemiol; 2019 Feb; 58():25-32. PubMed ID: 30445228 [TBL] [Abstract][Full Text] [Related]
18. Reproductive and hormonal factors and the risk of nonsmall cell lung cancer. Meinhold CL; Berrington de González A; Bowman ED; Brenner AV; Jones RT; Lacey JV; Loffredo CA; Perlmutter D; Schonfeld SJ; Trivers GE; Harris CC Int J Cancer; 2011 Mar; 128(6):1404-13. PubMed ID: 20473922 [TBL] [Abstract][Full Text] [Related]
19. Obesity and incidence of lung cancer: a meta-analysis. Yang Y; Dong J; Sun K; Zhao L; Zhao F; Wang L; Jiao Y Int J Cancer; 2013 Mar; 132(5):1162-9. PubMed ID: 22777722 [TBL] [Abstract][Full Text] [Related]
20. Exogenous hormone therapy and non-melanoma skin cancer (keratinocyte carcinoma) risk in women: a systematic review and meta-analysis. Li L; Pei B; Feng Y BMC Cancer; 2023 Oct; 23(1):946. PubMed ID: 37803321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]